Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.27.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.31.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.78NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HS.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.86 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.7 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.12 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.7.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.390NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.572NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.397NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.3 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.523NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.116 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.38 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.340NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.437NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.452NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used